HDHL Preventing peanut allergy through improved understanding of the transcutaneous sensitisation route, novel food processing and skin care
Lead Research Organisation:
King's College London
Department Name: Dermatology
Abstract
Allergic diseases, including atopic dermatitis and food allergies affect many children across Europe. The immune responses to oral food allergens are well-established and controlled oral allergen exposure methods in early life have been developed that can prevent food allergies.
There is mounting evidence that early life cutaneous exposure to foods causes sensitisation, especially in the presence of dry skin and atopic dermatitis. Despite this, very little is known about how the cutaneous sensitisation to food allergies occurs.
This project aims to reduce the risk of peanut allergy development through the transcutaneous route by understanding the mechanisms through which this occurs, and by designing and testing novel prevention approaches, such as modification in the peanut manufacturing processes and the adaptation of skin care practices.
These aims will be addressed through integrated projects undertaken taken forward by leaders in their respective fields from the UK, Germany, and France. Each of these projects will be known separately as work-plans. Work-plan 1 will look into the effects of food processing upon the solubility of peanut protein and its components in oil and how this relates to the cutaneous exposure to peanut protein. Work-plan 2 will examine the effect of peanut protein skin contamination and skin appendage trapping. Work-plan 3 will study the immune system activation induced by massage and cutaneous peanut exposure. Work-plan 4 will use an interventional study approach with skin massage to study the immune responses to peanut allergen in those with a skin barrier defect. Work-plan 5 will examine the cutaneous immune responses to peanut allergen in those suffering of peanut allergy, and, work-plan 6 will translate the overall findings through working with an industrial peanut processing partner, patients and consumers.
The discoveries derived from the project will be shared with industry partners, charities, national and international food standards agencies to ensure stakeholder awareness and to encourage the findings of our work to be translated into improved public health measures with the hope to ultimately to reduce the burden of peanut allergy at the population level.
There is mounting evidence that early life cutaneous exposure to foods causes sensitisation, especially in the presence of dry skin and atopic dermatitis. Despite this, very little is known about how the cutaneous sensitisation to food allergies occurs.
This project aims to reduce the risk of peanut allergy development through the transcutaneous route by understanding the mechanisms through which this occurs, and by designing and testing novel prevention approaches, such as modification in the peanut manufacturing processes and the adaptation of skin care practices.
These aims will be addressed through integrated projects undertaken taken forward by leaders in their respective fields from the UK, Germany, and France. Each of these projects will be known separately as work-plans. Work-plan 1 will look into the effects of food processing upon the solubility of peanut protein and its components in oil and how this relates to the cutaneous exposure to peanut protein. Work-plan 2 will examine the effect of peanut protein skin contamination and skin appendage trapping. Work-plan 3 will study the immune system activation induced by massage and cutaneous peanut exposure. Work-plan 4 will use an interventional study approach with skin massage to study the immune responses to peanut allergen in those with a skin barrier defect. Work-plan 5 will examine the cutaneous immune responses to peanut allergen in those suffering of peanut allergy, and, work-plan 6 will translate the overall findings through working with an industrial peanut processing partner, patients and consumers.
The discoveries derived from the project will be shared with industry partners, charities, national and international food standards agencies to ensure stakeholder awareness and to encourage the findings of our work to be translated into improved public health measures with the hope to ultimately to reduce the burden of peanut allergy at the population level.
Technical Summary
Our proposal aims to understand how peanut processing methods and peanut co-administration with oils, as is standard during the industrial processing of peanuts, influences the development of peanut allergy through the skin.
Cutaneous exposure of allergens is a crucial, but hitherto underexplored route of food sensitisation, that if understood could lead to the development of translatable strategies to prevent food allergy. Food processors require a greater understanding of how allergen exposure cause allergy so that they can adapt their processing methods to counteract these exposure processes. Furthermore, this proposed research aligns with on-going efforts across Europe to address the increasing problems associated with food allergy but it is unique in that it focuses on cutaneous allergen exposure, which is a field in desperate need of more systematic study.
The assembled team of investigators (from the UK, Germany and France) joined by a peanut industry partner (Levantine) and patient and consumer representatives will aim to address the following hypotheses:
Understanding the mechanisms by which:
> Peanut proteins pass into the skin via the appendages to trigger an immune response.
> Skin stretching that occurs during massage opens up the skin appendages allowing more peanut protein into the skin and leads to dendritic cell activation and induction of T helper 2 cell response.
> Co-administration of peanut proteins and an oil to the skin increases allergenicity.
> Skin barrier impairment and inflammation (AD) increases allergenicity.
Test novel approaches to peanut allergy prevention whereby:
> Modifications in peanut processing can reduce allergen exposure via the skin.
> Meticulous hand hygiene reduces skin contamination with peanut protein.
> Application of a barrier enhancing cream can strengthen the skin barrier, in particular in those with atopic dermatitis, and reduce the risk of transcutaneous sensitisation further.
Cutaneous exposure of allergens is a crucial, but hitherto underexplored route of food sensitisation, that if understood could lead to the development of translatable strategies to prevent food allergy. Food processors require a greater understanding of how allergen exposure cause allergy so that they can adapt their processing methods to counteract these exposure processes. Furthermore, this proposed research aligns with on-going efforts across Europe to address the increasing problems associated with food allergy but it is unique in that it focuses on cutaneous allergen exposure, which is a field in desperate need of more systematic study.
The assembled team of investigators (from the UK, Germany and France) joined by a peanut industry partner (Levantine) and patient and consumer representatives will aim to address the following hypotheses:
Understanding the mechanisms by which:
> Peanut proteins pass into the skin via the appendages to trigger an immune response.
> Skin stretching that occurs during massage opens up the skin appendages allowing more peanut protein into the skin and leads to dendritic cell activation and induction of T helper 2 cell response.
> Co-administration of peanut proteins and an oil to the skin increases allergenicity.
> Skin barrier impairment and inflammation (AD) increases allergenicity.
Test novel approaches to peanut allergy prevention whereby:
> Modifications in peanut processing can reduce allergen exposure via the skin.
> Meticulous hand hygiene reduces skin contamination with peanut protein.
> Application of a barrier enhancing cream can strengthen the skin barrier, in particular in those with atopic dermatitis, and reduce the risk of transcutaneous sensitisation further.
| Description | Too early to say (the award is still active) |
| Exploitation Route | Too early to say (the award is still active) |
| Sectors | Agriculture Food and Drink Pharmaceuticals and Medical Biotechnology |
| Description | A multiplexed micro-suction biomarker extraction device to understand atopic eczema in babies |
| Amount | £1,047,188 (GBP) |
| Funding ID | EP/X013251/1 |
| Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2023 |
| End | 07/2026 |
| Description | Understanding How Environmental Cutaneous Exposure To Peanut Protein Contributes to Food Allergy In Early Life |
| Amount | £190,000 (GBP) |
| Funding ID | CF-2021-2 108 |
| Organisation | Rosetrees Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 03/2023 |
| End | 01/2026 |
| Description | TRANS-FOODS Consortium - Charité - University of Medicine Berlin |
| Organisation | Charité - University of Medicine Berlin |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Prof. Carsten Flohr leads and coordinates the TRANS-FOODS Consortium and is responsible for delivering the project objectives on time and to budget. The consortium consists of integrated work packages headed by leaders in their respective fields from the UK, Germany, and France. The work headed by Prof. Carsten Flohr is an intervention study approach with skin massage to study the immune responses to peanut allergen in those with a skin barrier defect. In addition to this, Prof. Flohr and his team have set up scientific and steering committee meetings within the project, which enable discussion on the progress of the project and allow all collaborators within the consortium to feedback. This has led to development of the research conducted and discussions around disseminating the results of this project. |
| Collaborator Contribution | Prof. Martina Meinke, part of the Centre of Experimental and Applied Cutaneous Physiology within Charité - Universitätsmedizin Berlin is a collaborator on the TRANS-FOODS project, making up the consortium. In addition to attending and providing input within the meetings outlined above, Prof. Martina Meinke's team lead on examining the effect of peanut protein skin contamination and skin appendage trapping within the project. In December 2024, their team hosted a TRANS-FOODS meeting in Berlin to further our research discussions. |
| Impact | None yet. |
| Start Year | 2022 |
| Description | TRANS-FOODS Consortium - INSERM, Institut Curie |
| Organisation | Curie Institute Paris (Institut Curie) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Prof. Carsten Flohr leads and coordinates the TRANS-FOODS Consortium and is responsible for delivering the project objectives on time and to budget. The consortium consists of integrated work packages headed by leaders in their respective fields from the UK, Germany, and France. The work headed by Prof. Carsten Flohr is an intervention study approach with skin massage to study the immune responses to peanut allergen in those with a skin barrier defect. In addition to this, Prof. Flohr and his team have set up scientific and steering committee meetings within the project, which enable discussion on the progress of the project and allow all collaborators within the consortium to feedback. This has led to development of the research conducted and discussions around disseminating the results of this project. |
| Collaborator Contribution | Dr Elodie Segura, part of Centre d'Immunothérapie at INSERM, Institut Curie is a collaborator on the TRANS-FOODS project, making up the consortium. In addition to attending and providing input within the meetings outlined above, Dr Elodie Segura's team lead on studying the immune system activation induced by massage and cutaneous peanut exposure. |
| Impact | Darawan Tabtim-On from Dr Elodie Segura's team has so far submitted two separate abstracts and corresponding posters in 2023 and 2024. |
| Start Year | 2022 |
| Description | TRANS-FOODS Consortium - University of Bonn |
| Organisation | University of Bonn |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Prof. Carsten Flohr leads and coordinates the TRANS-FOODS Consortium and is responsible for delivering the project objectives on time and to budget. The consortium consists of integrated work packages headed by leaders in their respective fields from the UK, Germany, and France. The work headed by Prof. Carsten Flohr is an intervention study approach with skin massage to study the immune responses to peanut allergen in those with a skin barrier defect. In addition to this, Prof. Flohr and his team have set up scientific and steering committee meetings within the project, which enable discussion on the progress of the project and allow all collaborators within the consortium to feedback. This has led to development of the research conducted and discussions around disseminating the results of this project. |
| Collaborator Contribution | Prof. Natalija Novak, part of the Department of Dermatology and Allergy at the University of Bonn is a collaborator on the TRANS-FOODS project, making up the consortium. In addition to attending and providing input within the meetings outlined above, Prof. Natalija Novak's team lead on examining the cutaneous immune responses to peanut allergen in those suffering with peanut allergy. |
| Impact | None yet. |
| Start Year | 2022 |
